Agilent, GKC-224301, AdvanceBio G2FS2 α(2,6) / FA2G2S(6)2 N-glycan Standard

AdvanceBio G2FS2 α(2,6) / FA2G2S(6)2 N-glycan Standard. N-glycan (di-sialylated-, galactosylated biantennary complex, core-substituted with fucose). Qualitative standard for glycan identification. Alternative glycan names: G2FS2, FA2G2S2, F(6)A2G(4)2S(6)2, A2F.

Specifications:
Chemical Structure:
Label: Unlabeled
Monoisotopic Mass: 2368.8409
Name: G2FS2 (α2,6)
Oxford Name: F(6)A2G2S(6)2
Standard Type: Complex-type Native N-Glycan
Unit: 10 µg

**********The following product description is generated by AI and is for reference only. If you have any questions, please contact customer service.**********
This high-purity N-glycan standard delivers reliable analytical performance for glycan characterization and quantitation. Featuring the well-defined G2FS2 α2,6 linked sialylated glycan structure, it supports the identification and relative quantitation of complex biantennary glycan species, such as FA2G2S6(2). Ideally suited for researchers working on biotherapeutic glycosylation profiling, biosimilarity assessment, and quality control of monoclonal antibodies or other glycoproteins, the standard enables accurate method development and system suitability evaluation.

It is compatible with HPLC, UHPLC, and LC-MS workflows commonly employed for glycomic analysis, ensuring seamless integration into Agilent AdvanceBio Glycan Mapping solutions and other departmental protocols. The product is conveniently labeled for direct use in fluorescence or mass spectrometry-based detection platforms, reducing sample preparation time and improving reproducibility. When used alongside other glycan standards and Agilent glycan labeling kits, it aids in comprehensive glycan mapping, peak identification, and system calibration.

Strict quality control ensures batch-to-batch consistency, promoting confidence in comparative studies and regulatory submissions. With its robust performance and compatibility, this glycan standard is an essential tool for academic, clinical, and pharmaceutical laboratories focused on detailed N-glycan analysis.